| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5648888 | Journal of Dermatological Science | 2017 | 8 Pages |
Abstract
Our data demonstrate that IMI-Sol TCI can overcome current limitations of previous imiquimod based TCI approaches opening new perspectives for transcutaneous vaccination strategies and allowing the use of this enhanced cutaneous drug-delivery system to be tailored for the improved prevention and treatment of infectious diseases and cancers.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Pamela Aranda Lopez, Mark Denny, Ann-Kathrin Hartmann, Astrid Alflen, Hans Christian Probst, Esther von Stebut, Stefan Tenzer, Hansjörg Schild, Michael Stassen, Peter Langguth, Markus P. Radsak,